Clik here to view.
International Symposium on Wound Repair and Regeneration Kicks off at NCKU
TAINAN, Taiwan National Cheng Kung University (NCKU), southern Taiwan, hosted International Symposium on Wound Repair and Regeneration, October 8, to explore the fundamental approaches regarding...
View ArticleClik here to view.
艾本德宣布康涅狄格州已批准其进行生物安全2级传染病相关研究
Smart Multimedia Gallery Eppendorf Enfield Laboratory image of human mesenchymal stem cells (hMSCs) (Photo: Business Wire) View and Share Photo Download Small 康涅狄格州恩菲尔德...
View ArticleClik here to view.
エッペンドルフがバイオセーフティーレベル2の感染性疾患と関連した研究の実施につき、コネティカット州の承認を取得と発表
Smart Multimedia Gallery Eppendorf Enfield Laboratory image of human mesenchymal stem cells (hMSCs) (Photo: Business Wire) View and Share Photo Download Small 米コネティカット州エンフィールド （ビジネスワイヤ） —...
View ArticleClik here to view.
BioTime Organizes New ESI BIO Division to Develop, Manufacture and Market the...
ALAMEDA, Calif. BioTime, Inc. (NYSE MKT: BTX) today announced changes to the organization and management of its research products business. The research products business will be consolidated into a...
View ArticleClik here to view.
Cytori Licenses Asia-Pacific Cardiovascular, Renal & Diabetes Markets to...
SAN DIEGO & HONG KONG & BEIJING & MELBOURNE Cytori Therapeutics (NASDAQ: CYTX) and Lorem Vascular today announced a partnership to commercialize Cytori Cell Therapy for the...
View ArticleClik here to view.
Life Stem Genetics Announces LOI with Stem Cell Therapy Clinic in Dhaka,...
BEVERLY HILLS, Calif. Life Stem Genetics, Inc. (OTCBB:LIFS) (the“Company”) announces the signing of a Letter of Intent (“LOI”) between Life Stem Genetics, Inc. and Dr. Iqram Rahman (“IR”) in Dhaka,...
View ArticleClik here to view.
Terumo BCT发布 Quantum® 细胞扩增系统软件2.0版
科罗拉多州LAKEWOOD (美国商业资讯)–Terumo BCT已发布 Quantum系统的软件升级，这是该公司不断协助细胞疗法公司和研究组织的宗旨的一部分，符合现行药品优良制造规范(cGMP)和美国联邦法规(CFR)第11条。 有关QUANTUM 软件2.0版的关键事实 在细胞培养流程中通过电子化数据采集将传统的手工报告自动化。 在细胞培养流程破坏的情况下，通过定制远程警报提示通知用户。...
View ArticleClik here to view.
テルモBCTが細胞増殖システムQuantum®用ソフトウエア2.0版をリリース
米コロラド州レイクウッド （ビジネスワイヤ） — テルモBCTは現行適正製造基準（cGMP）に適合し、米国連邦規則集（CFR）第11章を順守する細胞治療企業・研究組織を支援すべく継続的に取り組んでいる目標の一環として、Quantumシステム用ソフトウエアの更新版をリリースしました。 QUANTUM用ソフトウエア2.0版に関する重要事実：...
View ArticleClik here to view.
Cytori Comments on New Legislation for Regenerative Medicine in Japan
SAN DIEGO Cytori Therapeutics (NASDAQ: CYTX) reports that on November 20, 2013, the Japanese legislature (Diet) approved new legislation targeted at regenerative medicine therapies. The Regenerative...
View ArticleClik here to view.
Data from Final Cohort of Patients in Patrys Multiple Myeloma Clinical Trial
MELBOURNE, Australia Patrys Limited (ASX:PAB), a clinical stage biotechnology company has announced that updated results from its PAT-SM6 Phase I/IIa clinical trial in multiple myeloma (MM) will be...
View ArticleClik here to view.
Promega ADCC Reporter Bioassay Named to The Scientist Top 10 Innovations for...
Smart Multimedia Gallery Representation of Promega ADCC Reporter Bioassay. Readout is luminescence signal from NFAT response element driving expression of firefly luciferase in the engineered Jurkat...
View ArticleClik here to view.
世界最大級のナノテクノロジー総合展「nano tech 2014」 開催
Smart Multimedia Gallery nano tech 2013 会場風景 （写真：ビジネスワイヤ） View and Share Photo Download Small 東京 （ビジネスワイヤ） — nano tech 実行委員会（委員長：大阪大学 川合知二教授）は、来る2014 年1 月29 日～31日の3 日間、東京ビッグサイトにて、“nano tech 2014”...
View ArticleClik here to view.
The World’s Largest Nanotechnology Exhibition & Conference: “nano tech 2014″...
Smart Multimedia Gallery A view from the ‘nano tech 2013′ venue (Photo: Business Wire) View and Share Photo Download Small TOKYO The nano tech Executive Committee (Chairman: Osaka University...
View ArticleClik here to view.
Roche and Genentech Acquire Unlimited Access to Open Monoclonal Technology’s...
PALO ALTO, Calif. Open Monoclonal Technology, Inc. (OMT), an innovator in transgenic research for discovery of human therapeutic antibodies, today announced that Genentech, a member of the Roche...
View ArticleClik here to view.
BioTime, Inc. Subsidiary OncoCyte Corporation Initiates Clinical Development...
ALAMEDA, Calif. BioTime, Inc. (NYSE MKT: BTX) and its subsidiary OncoCyte Corporation today announced that OncoCyte has initiated clinical development of its bladder cancer diagnostic test in both...
View ArticleClik here to view.
Solentim Expands Reach into China
BOURNEMOUTH, United Kingdom Solentim, the developer of imagers for single cell cloning and tools for shortening the upstream cell line development workflow, is pleased to announce that it has...
View ArticleClik here to view.
STC 生命科学股份有限公司，干细胞研究治疗中心帕金森患者治疗成功
韩国首尔 (美国商业资讯)– 在韩国首尔STC生命科学股份有限公司（李桂浩 董事长）的干细胞研究所（ 李尚燃 所长）和97.7 B&H医院（郑元柱 院长）的共同努力下，找到了利用间充质干细胞治疗的方法，对于神经系统的慢性、活动性、退行性的疾病，也就是帕金森疾病患者的治疗以成功告捷！...
View ArticleClik here to view.
STC Lifeが幹細胞研究治療センターでパーキンソン病患者の治療に成功
ソウル （ビジネスワイヤ） — STC Life Co., Ltd.（会長：KYE HO LEE）の幹細胞研究所と97.7 B&H Clinic（代表理事：WON JU JUNG）は、パーキンソン病患者の間葉系幹細胞治療を成功裏に完了しました。パーキンソン病は慢性進行性の神経変性疾患です。...
View ArticleClik here to view.
New Phase IIa Trial in the United States and Phase III Trial in Kazakhstan...
SAN DIEGO CardioCell LLC announces two new clinical trials using its allogeneic stem-cell therapy to treat subjects with acute myocardial infarction (AMI), a problem facing more than 1.26 million...
View ArticleClik here to view.
STC Life Co., Ltd. Successfully Treats Patients With Parkinson’s Disease at...
SEOUL Stem cell research institute of STC Life Co., Ltd. (Chairman: KYE HO LEE) and 97.7 B&H Clinic (Director: WON JU JUNG) successfully completed mesenchymal stem cell therapy for the patients...
View Article